JD, S., R, K., R, C., A, G., M, H., I, A., & M, L. (2024). A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study. Headache, 64(10), 1264. https://doi.org/10.1111/head.14835
Chicago Style (17th ed.) CitationJD, Sharon, Krauter R, Chae R, Gardi A, Hum M, Allen I, and Levin M. "A Placebo Controlled, Randomized Clinical Trial of Galcanezumab for Vestibular Migraine: The INVESTMENT Study." Headache 64, no. 10 (2024): 1264. https://doi.org/10.1111/head.14835.
MLA (9th ed.) CitationJD, Sharon, et al. "A Placebo Controlled, Randomized Clinical Trial of Galcanezumab for Vestibular Migraine: The INVESTMENT Study." Headache, vol. 64, no. 10, 2024, p. 1264, https://doi.org/10.1111/head.14835.
Warning: These citations may not always be 100% accurate.